and hip fracture between those calculated with BMD and those without BMD measurements (P>0.05) respectively among female patients (n=32 Background: Osteoporosis is defined as a progressive, systemic skeletal disorder characterized by low bone mass and micro-architectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. There are numerous hip fracture risks. Bone mineral density (BMD) and T-score measured by dual-energy X-ray absorptiometry (DXA) are the main determinants of the clinical evaluation of hip fracture risk. World Health Organization classification defined osteoporosis as T-score below -2.5 SD. Objectives: The aim of this study was to estimate differences in DXA measurements (BMD and T-score of the spine) and potential predictors of the femoral neck fracture in the patients with osteoporosis. Methods: This study included 181 patients with osteoporosis (165 female and 16 male), average age of the 65, 6±8.5 years (range of 44.1 to 87.3 years). Eighty one patients had fracture of the femoral neck. All patients in this group were managed operatively by hip arthroplasty, after clinical and radiological diagnostic procedures. DXA measurement was performed on Advanced Prodigy Lunar device for these patients postoperatively. BMD of the femoral neck was measured on the no operated side. Age, sex, height, weight, BMI, BMD and T-score of the spine at the level of L1-L4, BMD of the right and left femoral neck were estimated. The control group included 100 patients with osteoporosis (93 female and 7 male), average age of the 65.1±8, 5 years. Student's t-test and Logistic regression were used for statistical analysis. Dependent variable was presence of the fracture of the femoral neck and independent variables were age, sex, height, weight, BMI, BMD and T-score of the spine and BMD of the femoral neck. Results: Results of our study showed statistically significant difference between T-score of the spine (t=-2,973, p<0.01) as well as between BMD of the spine (t=-12,376, p<0.001) of patients with and without fracture of the femoral neck. T-score of the spine was significant predictor of fracture of the femoral neck (p<0, 01) when controlled by age, sex, height, weight, BMI, BMD of the spine, BMD of the femoral neck. Conclusions: T-score and BMD of the spine were statistically significantly lower in patients with fracture of the femoral neck than in patients with osteoporosis without fracture. T-score of the lumbar spine was significant predictor of fracture of the femoral neck in patients with osteoporosis. Probability of femur neck fractures increased with the decrease of T-score of lumbar spine in patients with osteoporosis. These results can help in predicting femur neck fractures. 
AB0857 PROBLEMS OF DIAGNOSTICS AND PROPHYLAXIS OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN REAL CLINICAL PRACTICE

S. Yakupova, R. Demidov. Kazan State Medical University, Kazan, Russian Federation
Background: Oral glucocorticoids (GC) are used in different medicine fields and appear as risk factors of glucocorticoid-induced osteoporosis (GIO). Objectives: The aim is to estimate the frequency of use of prophylaxis of OP, use drugs that are approved for GIO and also an awareness of GIO of patients with prolonged intake of GC. Methods: 50 patients (10 men and 40 women), taking GC, took part in research. 30 patients (60%) were from rheumatology department, 5 patients (10%) from pulmonology department, 5 patients (10%) from gastroenterology department, 10 patients (20%) from nephrology department of Republic Clinical Hospital. Mean age of patients -48,84±14,03 years (from 26 to 73). The following signs were estimated: clinical data, osteoporosis risk factors, instrumental tests (X-ray, densitometry). FRAX assessment of fracture risk was performed, the questionnaires of patients' awareness of GIO was completed. Results: The duration of intake GC -5,93±4,86 years. Minimal dose of GC per day (if receiving prednisone) -7.5 mg; maximal dose -60 mg. 10-year risk of major osteoporotic fractures by FRAX, adjusted according to GC dose -18,11±11,01. 32 patients (64%) were given recommendations for changing lifestyle and diet for GIO prophylaxis, 40 patients (80%) -recommendations for intake of calcium and vitamin D medications, but only 31 patients (62%) followed recommendations and started the intake of calcium medications. From the said number of patients only 14 patients (45,2%) used appropriate daily dose of calcium and vitamin D. Drugs that are approved for GIO were have to be prescribed for 18 patients, but only 6 patients (33,3%) underwent treatment, principally bisphosphonates. Only half of them underwent densitometry after starting the therapy. 72,2% patients with GIO used calcium and 30,7% were taking appropriate daily dose of calcium and vitamin D. 70% rheumatologic patients knew about GIO and in 90% cases calcium and vitamin D drugs were recommended. Only 50% of patients from non-rheumatologic departments knew about GIO and in 65% cases calcium and vitamin D drugs were recommended. Conclusions: Clinical recommendations in real clinical practice are rarely fulfilled. Less than 60% patients were taking calcium and vitamin D, which are recommended for all patients, who started the GC therapy; only 33% of patients received osteoporosis therapy, only half of them underwent densitometry. Patients are insufficiently informed about necessity of changing lifestyle and diet for GIO prophylaxis. Education for patients taking GC and training for rheumatologic and non-rheumatologic specialties are necessary. Background: Diabetes mellitus has shown to be a significant risk factor for the development and prognosis of heart failure (HF) and associated with an increased risk of fractures [1] . Osteoporosis and heart failure are generally considered two distinct diseases, but recent evidence suggests a link between both diseases. Objectives: The aim of the study was to investigate the association of bone mineral density with the risk of developing heart failure in diabetic patients. Methods: 85 patients both sexes with type 2 diabetes aged 58.69±9.07 years were studied. Besides standard laboratory parameters, the echocardiographic and BMD measurements were performed. Estimated glomerular filtration rate was measured. Results: Among diabetic subjects, 8 patients (9.4%) had osteoporosis, 21 (24.8%) had osteopenia and 56 (65.8%) had a normal BMD. Increased serum NT-proBNP (p<0.001) and decreased left ventricular ejection fraction (EF) (p=0.03) were significantly correlated with low T-score L1-L4 cutoff points between groups (normal, osteopenia, and osteoporosis). Multivariate stepwise linear regression analysis of the significant variables revealed that NT-proBNP, EF were independent predictors of lumbar BMD among female patients with diabetes mellitus. After adjusting for age, gender, and related comorbidities, the osteoporosis group was associated with a significantly higher risk of coronary artery disease in women with diabetes. However, no association between BMD and HF was found in men. Conclusions: Osteoporosis may be an independent factor for HF in women with diabetes mellitus. Our data suggested that early detection of abnormal BMD should warrant for early search of undetected HF in diabetic women. A further study is needed to elucidate the effects of BMD on cardiac function in diabetic patients.
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